Brain sterol dysregulation in sporadic AD and MCI: relationship to heme oxygenase-1.
The objective of this study was to ascertain the impact of aging and Alzheimer's disease (AD) on brain cholesterol (CH), CH precursors, and oxysterol homeostasis. Altered CH metabolism and up-regulation of heme oxygenase-1 (HO-1) are characteristic of AD-affected neural tissues. We recently determined that HO-1 over-expression suppresses total CH levels by augmenting liver X receptor-mediated CH efflux and enhances oxysterol formation in cultured astroglia. Lipids and proteins were extracted from postmortem human frontal cortex derived from subjects with sporadic AD, mild cognitive impairment (MCI), and no cognitive impairment (n = 17 per group) enrolled in the Religious Orders Study, an ongoing clinical-pathologic study of aging and AD. ELISA was used to quantify human HO-1 protein expression from brain tissue and gas chromatography-mass spectrometry to quantify total CH, CH precursors, and relevant oxysterols. The relationships of sterol/oxysterol levels to HO-1 protein expression and clinical/demographic variables were determined by multivariable regression and non-parametric statistical analyses. Decreased CH, increased oxysterol and increased CH precursors concentrations in the cortex correlated significantly with HO-1 levels in MCI and AD, but not no cognitive impairment. Specific oxysterols correlated with disease state, increasing neuropathological burden, neuropsychological impairment, and age. A model featuring compensated and de-compensated states of altered sterol homeostasis in MCI and AD is presented based on the current data set and our earlier in vitro work.
Hascalovici
Jacob R
JR
Centre for Neurotranslational Research, Lady Davis Institute for Medical Research, Montreal, Quebec, Canada.
Vaya
Jacob
J
Khatib
Soliman
S
Holcroft
Christina A
CA
Zukor
Hillel
H
Song
Wei
W
Arvanitakis
Zoe
Z
Bennett
David A
DA
Schipper
Hyman M
HM
D000368:Aged; D000369:Aged, 80 and over; D000375:Aging / Q000378:metabolism / Q000473:pathology; D000544:Alzheimer Disease / Q000378:metabolism* / Q000503:physiopathology; D001344:Autopsy; D001921:Brain / Q000378:metabolism* / Q000503:physiopathology; D002784:Cholesterol / Q000378:metabolism; D003072:Cognition Disorders / Q000378:metabolism* / Q000503:physiopathology; D015331:Cohort Studies; D018450:Disease Progression; D004789:Enzyme Activation / Q000502:physiology; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D008401:Gas Chromatography-Mass Spectrometry; D051547:Heme Oxygenase-1 / Q000032:analysis / Q000378:metabolism*; D006801:Humans; D008297:Male; D008569:Memory Disorders / Q000378:metabolism / Q000503:physiopathology; D008959:Models, Neurological; D009410:Nerve Degeneration / Q000378:metabolism / Q000503:physiopathology; D009474:Neurons / Q000378:metabolism / Q000473:pathology; D013261:Sterols / Q000378:metabolism*; D015854:Up-Regulation / Q000502:physiology
D013261:Sterols; D002784:Cholesterol; D051547:Heme Oxygenase-1